Loading company…
Synthego, based in Redwood City, California, provides genome engineering software and synthetic RNA kits for research.
Founded in 2012 and based in California, US, Synthego Corporation provides genome engineering solutions, including software and synthetic RNA kits for genome editing and research. Its Eclipse platform supports CRISPR editing, and its Halo platform offers gene-editing tools for drug discovery. In August 2020 the company raised USD 100 million in Series D funding co-led by RA Capital and Wellington Management, with existing investor 8VC. Paul Dabrowski is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in